BRAINTREE, Mass., June 14, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) will webcast the management presentations and the question and answer period of its investor and analyst meeting on Monday, June 19, 2017 from 11:00am to 1:00pm Eastern Time.
Participants will include Haemonetics' CEO, Christopher Simon, and CFO, William Burke, as well as leaders of the Company's Plasma, Hospital and Blood Center business units.
Analysts, shareholders, and other audiences are invited to participate via live webcast. Webcast link: http://edge.media-server.com/m/p/42mzp3ed.
Alternatively, the webcast can be accessed via the Investor Relations section of the Company's website at www.haemonetics.com.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative hematology products and solutions, to help customers improve patient care and reduce the cost of healthcare. The Company's technologies address important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
CONTACT:
Gerry Gould, VP- Investor Relations
(781) 356-9402
gerry.gould@haemonetics.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/haemonetics-will-webcast-investor-and-analyst-meeting-300474184.html
SOURCE Haemonetics Corporation
